pubmed-article:8668804 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0205054 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0016911 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:8668804 | lifeskim:mentions | umls-concept:C1548161 | lld:lifeskim |
pubmed-article:8668804 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:8668804 | pubmed:dateCreated | 1996-8-5 | lld:pubmed |
pubmed-article:8668804 | pubmed:abstractText | To investigate enhancement with gadolinium benzyloxypropionictetraacetate (BOPTA) at magnetic resonance (MR) imaging to detect focal malignant hepatic lesions. | lld:pubmed |
pubmed-article:8668804 | pubmed:language | eng | lld:pubmed |
pubmed-article:8668804 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8668804 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8668804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8668804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8668804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8668804 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8668804 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8668804 | pubmed:month | May | lld:pubmed |
pubmed-article:8668804 | pubmed:issn | 0033-8419 | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:NicollMM | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:PistolesiG... | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:MoranaGG | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:SpinazziAA | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:CaudanaRR | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:PortueseAA | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:PirovanoG PGP | lld:pubmed |
pubmed-article:8668804 | pubmed:author | pubmed-author:Di RitoRR | lld:pubmed |
pubmed-article:8668804 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8668804 | pubmed:volume | 199 | lld:pubmed |
pubmed-article:8668804 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8668804 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8668804 | pubmed:pagination | 513-20 | lld:pubmed |
pubmed-article:8668804 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:meshHeading | pubmed-meshheading:8668804-... | lld:pubmed |
pubmed-article:8668804 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8668804 | pubmed:articleTitle | Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application. | lld:pubmed |
pubmed-article:8668804 | pubmed:affiliation | Department of Radiology, University of Verona, Italy. | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:8668804 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8668804 | lld:pubmed |